Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database
| Autor: | Christine S. M. Lau, Krishnaraj Mahendraraj, Ronald S. Chamberlain |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Pediatrics
medicine.medical_specialty Bevacizumab Improved survival computer.software_genre Temporal lobe 03 medical and health sciences 0302 clinical medicine Epidemiology medicine Original Research brain cancer Database Adult patients business.industry medicine.disease oligodendroglioma SEER database Oncology Frontal lobe Cancer Management and Research 030220 oncology & carcinogenesis Oligodendroglioma business computer 030217 neurology & neurosurgery medicine.drug Pediatric population |
| Zdroj: | Cancer Management and Research |
| ISSN: | 1179-1322 |
| Popis: | Christine SM Lau,1,2 Krishnaraj Mahendraraj,1 Ronald S Chamberlain1–4 1Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA; 2Saint George’s University School of Medicine, Grenada, West Indies; 3Department of Surgery, New Jersey Medical School, Rutgers University, Newark, NJ, 4Department of Surgery, Banner MD Anderson Cancer Center, Gilbert, AZ, USA Introduction: Oligodendrogliomas (OGs) account for 4cm in size. Children typically present with tumors in the temporal lobe, while adults present with tumors in the frontal lobe. Surgical resection confers a survival advantage among all patients, especially pediatric patients. Overall survival (OS) and cancer-specific survival are higher in the pediatric population. Further studies on novel treatment techniques, including bevacizumab and immunotherapy approaches, are required. Keywords: oligodendroglioma, brain cancer, SEER database |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|